Johnson & Johnson and GlaxoSmithKline are leading research into new antibiotics - but a new report has called for further action to combat the rise of drug-resistant bacteria.<
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
